在眼部粘膜中注射后,聚乙烯瓜尼丁衍生物的临床前药理动力学和组织分布
Ivan Ivanov1, Denis Shatalov1, Daria Kirillova1
1MIREA - Russian Technological University, Institute of Fine Chemical Technologies named after M.V. Lomonosov, Moscow, Russia.
Environmental analysis, health and toxicology
|February 12, 2026
概括
聚乙烯瓜尼丁衍生物 (ss-PHMGd) 的新型眼科盐眼滴显示系统风险较低. 在临床前模型中的药理动力学研究证实了最小的吸收和器官透,确保了眼睛的安全性.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 抗生素耐药性是一个日益严重的全球健康问题.
- 对眼部感染至关重要的消毒剂可能会诱导微生物耐药性.
- 评估新的眼科药物的全身副作用至关重要.
研究的目的:
- 为了评估多甲基瓜尼丁衍生物 (ss-PHMGd) 眼滴的盐的全身作用.
- 在临床前模型中,在眼部灌注后确定ss-PHMGd的药理学概况.
- 评估与ss-PHMGd眼科治疗相关的全身副作用的安全性和风险.
主要方法:
- 使用简单的数学模型对几内亚猪和辛奇拉子进行药理动力学分析.
- 在静脉和眼部注射后,在器官和组织中定量标记的ss-PHMGd.
- 评估脏分泌和药物动力学参数的剂量线性 (AUC-D).
主要成果:
- ss-PHMGd眼液的系统吸收和器官透率最低.
- 在几内亚猪和辛奇拉子之间没有观察到ADME参数的显著物种特异性差异.
- 药物动力学参数显示剂量线性,脏分泌占给药剂量的5.3%.
结论:
- 基于ss-PHMGd的眼科溶液具有较低的全身副作用风险.
- 这项研究提供了在眼部应用中对聚氨酸化合物的关键药理动力学和安全性数据.
- 这些发现支持ss-PHMGd在眼科治疗中的安全使用,有助于评估毒理风险.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
267
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
267
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
296
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
296
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
251
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
251
Drug Distribution: Tissue Binding
4.1K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
4.1K
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
369
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
369


